Solexa transfers listing to Nasdaq National Market

By Lisa Kerner

Erie, Pa., Feb. 21 - Solexa, Inc. said the Nasdaq Stock Market has approved the company's application to transfer its listing to The Nasdaq National Market from The Nasdaq Capital Market, which was formerly known as The Nasdaq SmallCap Market.

Solexa's common stock will begin trading today on The Nasdaq National Market under the symbol SLXA, according to a company news release.

Solexa is developing and preparing to commercialize the Solexa Genome Analysis System, which will be used to perform a range of analyses including whole genome resequencing, gene expression analysis and small-RNA analysis. The company's U.S. operations are based in Hayward, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.